{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:05:24Z","timestamp":1793289924420,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ajog.2023.04.031","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T20:32:00Z","timestamp":1682627520000},"page":"410-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-4061","authenticated-orcid":false,"given":"Rebecca","family":"Horgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Hage Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerri","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Abuhamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.04.031_bib1","series-title":"Hypertension in pregnancy: quality standard","year":"2013"},{"key":"10.1016\/j.ajog.2023.04.031_bib3","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib4","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: Green-top Guideline No. 72","volume":"126","author":"Denison","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.04.031_bib5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","article-title":"Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin","volume":"325","author":"Clarke","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.031_bib6","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.031_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2023.04.031_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2023.04.031_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on\u00a0the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib11","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.04.031_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib13","first-page":"1","article-title":"Increases in prepregnancy obesity: United States, 2016\u20132019","volume":"392","author":"Driscoll","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajog.2023.04.031_bib14","doi-asserted-by":"crossref","first-page":"385:e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.08.047","article-title":"Does low-dose aspirin initiated before 11 weeks\u2019 gestation reduce the rate of preeclampsia?","volume":"222","author":"Chaemsaithong","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.031_bib18","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.031_bib19","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/AOG.0000000000002351","article-title":"Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum hemorrhage","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib20","doi-asserted-by":"crossref","first-page":"95:e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.04.031_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (collaborative low-dose aspirin study in pregnancy) collaborative group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.031_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.031_bib24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/GCO.0000000000000846","article-title":"Aspirin in pregnancy: a review of indications, timing, dosing and efficacy","volume":"35","author":"Joudi","year":"2023","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.04.031_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (Aspirin): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.031_bib29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jogc.2020.05.013","article-title":"A pilot randomized rrial comparing the effects of 80 versus 160 mg of aspirin on midtrimester uterine artery pulsatility index in women with a history of preeclampsia","volume":"42","author":"Tapp","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2023.04.031_bib30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/aogs.13420","article-title":"Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: A randomized controlled trial","volume":"97","author":"Blomqvist","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2023.04.031_bib31","first-page":"5013","article-title":"Effect of regular oral intake of aspirin during pregnancy on pregnancy outcome of high-risk pregnancy-induced hypertension syndrome patients","volume":"20","author":"Liu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ajog.2023.04.031_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/uog.14889","article-title":"Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial","volume":"46","author":"Odibo","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/AOG.0000000000000736","article-title":"Low-dose aspirin and preterm birth: a randomized controlled trial","volume":"125","author":"Silver","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ajog.2023.04.031_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of\u00a0randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.04.031_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/hr.2011.111","article-title":"Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation","volume":"34","author":"Bakhti","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2023.04.031_bib37","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.031_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/humrep\/den489","article-title":"Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF\/ICSI: a randomized, placebo-controlled, double-blind study","volume":"24","author":"Haapsamo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2023.04.031_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2008.07.1759","article-title":"Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial","volume":"92","author":"Lambers","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2023.04.031_bib40","first-page":"826","article-title":"Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial","volume":"46","author":"Ebrashy","year":"2005","journal-title":"Croat Med J"},{"key":"10.1016\/j.ajog.2023.04.031_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.04.031_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.218","article-title":"Fetal Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0301-2115(03)00269-0","article-title":"A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia","volume":"112","author":"Chiaffarino","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.04.031_bib44","first-page":"161","article-title":"Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches","volume":"109","author":"Vainio","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.04.031_bib45","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1067\/mob.2000.106754","article-title":"Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial","volume":"183","author":"Pattison","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib46","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.HYP.34.4.1016","article-title":"Administration time-dependent effects of aspirin in women at differing risk for preeclampsia","volume":"34","author":"Hermida","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.04.031_bib47","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.031_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group","volume":"105","author":"Golding","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0020-7292(97)00257-9","article-title":"A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia","volume":"60","author":"Byaruhanga","year":"1998","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2023.04.031_bib51","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.HYP.30.3.589","article-title":"Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women","volume":"30","author":"Hermida","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.04.031_bib52","first-page":"71","article-title":"Clinical efficacy of Doppler ultrasound for low dose aspirin therapy in high risk pregnancy","volume":"40","author":"Kim","year":"1997","journal-title":"Korean J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib53","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2023.04.031_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","article-title":"randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Preven\u00e7\u00e3o da Pr\u00e9-eclampsia com Aspirina) Collaborative Group","volume":"103","author":"ECPPA","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0029-7844(95)00340-1","article-title":"A randomized controlled trial of\u00a0aspirin in patients with abnormal uterine artery\u00a0blood flow","volume":"87","author":"Morris","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10641959509058050","article-title":"Low-dose aspirin in the prevention of hypertensive disorders of pregnancy in relatively low-risk nulliparous women","volume":"14","author":"Davies","year":"1995","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.04.031_bib57","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0002-9378(95)90356-9","article-title":"The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy","volume":"173","author":"Kyle","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib58","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in\u00a0healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.031_bib59","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","article-title":"Low-dose aspirin therapy to prevent preeclampsia","volume":"168","author":"Hauth","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.031_bib60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000292748","article-title":"Low-dose aspirin in primigravidae with positive roll-over test","volume":"34","author":"Schr\u00f6cksnadel","year":"1992","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2023.04.031_bib61","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0140-6736(90)91377-M","article-title":"Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension","volume":"335","author":"McParland","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.031_bib62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk\u00a0pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.031_bib63","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823002697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823002697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:41:34Z","timestamp":1757590894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823002697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0002937823002697"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.04.031","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}